Pilot Study Finds Blueberries Shift Gut Genes in Seniors, But Mood Benefits Remain Uncertain

Key points

• A double-blind pilot study tested 48 grams of blueberry powder daily (equivalent to two cups of fresh berries) against a placebo in 18 sedentary adults aged 65 and older with mild depressive symptoms.
• The blueberry group exhibited significant changes in microbial genes associated with polyamine-transporting ATPase, a process involved in producing the neurotransmitter GABA, though no corresponding changes were seen in short-chain fatty acids or overall microbial species abundance.
• Participants consuming blueberries reported greater reductions in depressive symptoms compared to the placebo group, but the difference did not reach statistical significance, leaving the clinical benefit uncertain.
• Lead researcher Courtney L. Millar from Hebrew SeniorLife’s Hinda and Arthur Marcus Institute for Aging Research emphasized that while fiber and anthocyanins can modify the gut microbiome, establishing a direct link to mood improvement requires evidence beyond these microscopic changes.
• The study, published in The Journal of Nutrition, Health and Aging, was funded by the USDA and the National Institute on Aging, aiming to preliminarily determine the effects of blueberry intake on the gut-brain axis in older adults.

Background

Recent research has increasingly explored the gut-brain axis, with earlier studies suggesting that walnuts and coffee can influence mood and sleep through microbiome alterations. This new study adds to the growing body of evidence examining how dietary compounds like anthocyanins may impact mental health in aging populations, though it remains a preliminary pilot trial.

Why it matters

As the global population ages, finding non-pharmacological interventions for mild depressive symptoms is a priority. If blueberries are confirmed to alleviate depression through gut microbiome modulation, it could offer a simple, accessible dietary strategy for improving mental health in seniors. However, the lack of statistical significance in this small trial means that definitive claims cannot be made, and larger, controlled studies are necessary to determine if these subtle gut changes translate into meaningful clinical benefits for mood and overall well-being.

What to watch

Researchers will likely need to conduct larger, randomized controlled trials to confirm whether the observed genetic shifts in the gut microbiome actually lead to improved mood and reduced depressive symptoms. Future studies may also investigate specific anthocyanin compounds and their direct effects on neurotransmitter production, such as GABA, to better understand the mechanisms behind the gut-brain axis in older adults.